Literature DB >> 8476229

Cytotoxic activity of fusaric acid on human adenocarcinoma cells in tissue culture.

J A Fernandez-Pol1, D J Klos, P D Hamilton.   

Abstract

When cultured human normal WI-38 fibroblasts were exposed to 500 microM fusaric acid (5-butylpicolinic acid), cell proliferation ceases. The majority of the WI-38 cells remained in a quiescent G1(G0) state and viable for approximately 30 to 48 h. The effect of fusaric acid on WI-38 cell growth was slowly reversible after removal of the agent from the culture media. In contrast, within 24 h of exposure to 500 microM fusaric acid, most of the human colon adenocarcinoma LoVo cells were blocked at random in the cell cycle and approximately 80% of the cells were dead after 30 h. Three additional human colorectal adenocarcinoma cell lines, denoted SW48, SW480, and SW742, were also sensitive to the inhibitory and cytotoxic effects of fusaric acid. Of all the cell lines tested, the human mammary adenocarcinoma cell line MDA-MB-468 was the most sensitive to the growth inhibitory and cytotoxic effects of fusaric acid. Further experiments with MDA-MB-468 cells demonstrated that fusaric acid is a potent inhibitor of DNA synthesis. Fusaric acid also inhibited the growth of human epidermoid carcinoma KB cells and showed cytotoxic actions for this cell line but its effects on cell viability were not as pronounced. The results presented here indicate that fusaric acid has potent anti-proliferative activity in vitro on various normal and cancer cell lines and suggest that it exhibits some cytotoxic specificity for growing and confluent colorectal adenocarcinoma and mammary adenocarcinoma cell lines.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8476229

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  The effect of single agent oral fusaric acid (FA) on the growth of subcutaneously xenografted SCC-1 cells in a nude mouse model.

Authors:  James M Ruda; Kirt S Beus; Christopher S Hollenbeak; Ronald P Wilson; Brendan C Stack
Journal:  Invest New Drugs       Date:  2006-09       Impact factor: 3.850

2.  Fusaric acid-induced promoter methylation of DNA methyltransferases triggers DNA hypomethylation in human hepatocellular carcinoma (HepG2) cells.

Authors:  Terisha Ghazi; Savania Nagiah; Pragalathan Naidoo; Anil A Chuturgoon
Journal:  Epigenetics       Date:  2019-05-16       Impact factor: 4.528

3.  Toxic interaction of fumonisin B1 and fusaric acid measured by injection into fertile chicken egg.

Authors:  C W Bacon; J K Porter; W P Norred
Journal:  Mycopathologia       Date:  1995       Impact factor: 2.574

4.  Determination of oral bioavailability of fusaric acid in male Sprague-Dawley rats.

Authors:  Brendan C Stack; John Ye; Rebecca Willis; Martha Hubbard; Howard P Hendrickson
Journal:  Drugs R D       Date:  2014-06

5.  Production of siderophores increases resistance to fusaric acid in Pseudomonas protegens Pf-5.

Authors:  Jimena A Ruiz; Evangelina M Bernar; Kirsten Jung
Journal:  PLoS One       Date:  2015-01-08       Impact factor: 3.240

Review 6.  The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors.

Authors:  Tamera D Hughes; Osman F Güner; Emma Carine Iradukunda; Robert S Phillips; J Phillip Bowen
Journal:  Molecules       Date:  2022-01-02       Impact factor: 4.411

7.  Concise Total Synthesis and Antifungal Activities of Fusaric Acid, a Natural Product.

Authors:  Bin Bin Huang; Ya Yi Liu; Peng Fei Zhu; Yi Cheng Jiang; Ming-An Ouyang
Journal:  Molecules       Date:  2020-08-25       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.